News

Daily Pill Gives New Hope to Pancreatic Cancer Patients, Doctors Say

A new daily pill is giving fresh hope to people living with pancreatic cancer, one of the hardest cancers to treat in the world. Doctors say the drug, called daraxonrasib, has shrunk tumours in some patients and, in a few cases, made the cancer disappear from scans.

In early medical trials, one out of every 12 patients who took daraxonrasib together with chemotherapy had cancer that could no longer be seen on scans. In another group of 61 patients who had recently been diagnosed with advanced pancreatic cancer that had already spread to other parts of the body, tumours stopped growing in almost all of them.

Pancreatic cancer is feared because it is often found late, when it has already spread and cannot be removed through surgery. Chemotherapy can shrink the tumours a little, but the cancer usually grows back. For most patients with advanced disease, survival is counted in months, not years. In the UK, it has the lowest survival rate among the common cancers.

Cancer Research UK described the results as the biggest leap forward in decades for pancreatic cancer patients. Dr Sam Godfrey from the charity told BBC News that the drug has found a way of “drugging the undruggable”. He added that progress in pancreatic cancer was long overdue.

Scientists have chased this kind of treatment for years. Most pancreatic cancers are driven by changes in a protein family called RAS, but those proteins were very hard to block with medicine. Daraxonrasib is taken once a day by mouth and is designed to switch off several common RAS changes at once. It is made by Revolution Medicines, and a larger global trial with 500 patients found it nearly doubled survival for patients who had already received one round of chemotherapy. Nature magazine reported that average survival in that trial rose to 13.2 months.

Even so, doctors are asking people not to get carried away. The patients in the early trials were followed for about a year and a half on average, and some did not see their cancer return during that time. But nobody can yet say how long the drug will keep the disease under control, and doctors stress that it should not be seen as a cure. They say longer studies are needed to find out whether any of these cancers can be put into remission, and for how long.

Still, many specialists believe the pill could give patients something they have rarely had: more time, and better quality of that time.

Related Articles

Back to top button